Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alessandro Strusi"'
Autor:
Alessio Stefani, Geny Piro, Francesco Schietroma, Alessandro Strusi, Emanuele Vita, Simone Fiorani, Diletta Barone, Federico Monaca, Ileana Sparagna, Giustina Valente, Miriam Grazia Ferrara, Ettore D’Argento, Mariantonietta Di Salvatore, Carmine Carbone, Giampaolo Tortora, Emilio Bria
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Lung cancer is one of the most aggressive malignancies, classified into two major histological subtypes: non-small cell lung cancer (NSCLC), that accounts for about 85% of new diagnosis, and small cell lung cancer (SCLC), the other 15%. In the case o
Externí odkaz:
https://doaj.org/article/6bac46ddc4a44af59da25d1f0598743d
Autor:
Annunziato Anghelone, Alessandro Strusi, Alessandro Scala, Martina Panebianco, Chiara Ciccarese, Roberto Iacovelli
Publikováno v:
Expert Review of Anticancer Therapy. :1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f63db6844e8bc7259b1523e9761edacc
https://doi.org/10.1080/14737140.2023.2218091
https://doi.org/10.1080/14737140.2023.2218091
Autor:
Chiara Ciccarese, Alessandro Strusi, Daniela Arduini, Pierluigi Russo, Giuseppe Palermo, Nazario Foschi, Marco Racioppi, Giampaolo Tortora, Roberto Iacovelli
Publikováno v:
Cancer Treatment Reviews. 115:102528
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ebf7c8d4df274ea7afab39579931dc0
https://doi.org/10.1016/j.ctrv.2023.102528
https://doi.org/10.1016/j.ctrv.2023.102528
Autor:
Roberto Iacovelli, Daniela Arduini, Chiara Ciccarese, Francesco Pierconti, Alessandro Strusi, Geny Piro, Carmine Carbone, Nazario Foschi, Gennaro Daniele, Giampaolo Tortora
Publikováno v:
Critical reviews in oncology/hematology. 176
Hereditary and sporadic renal cell carcinomas (RCCs) are often associated with Von Hippel-Lindau (VHL)-gene inactivation. Patients with VHL disease have an increased risk of RCC, leading to bilateral nephrectomy and dialysis. In patients with advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d14e7c70648adc1215e32097081016fe
https://pubmed.ncbi.nlm.nih.gov/35728738
https://pubmed.ncbi.nlm.nih.gov/35728738
Autor:
Chiara Ciccarese, Davide Bimbatti, Francesco Atzori, Adele Bonato, Sarah Scagliarini, Ilaria Pellegrini, Sergio Bracarda, Ugo De Giorgi, Cristina Masini, Matteo Santoni, Francesco Massari, Sebastiano Buti, Alessandra Damassi, Ilaria Zampiva, Alessandro Strusi, Ileana Sparagna, Sara Elena Rebuzzi, Giampaolo Tortora, Roberto Iacovelli
Publikováno v:
Journal of Clinical Oncology. 40:349-349
349 Background: 25-30% of renal cell carcinoma presents with metastases (mRCC) at diagnosis. The activity of immune checkpoint inhibitor (ICI)-combinations on the primary tumor (PT) is debated. Patients and Methods: mRCC patients (pts) with PT who re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1e0fd58a26be8a242d61433253dc946
https://doi.org/10.1200/jco.2022.40.6_suppl.349
https://doi.org/10.1200/jco.2022.40.6_suppl.349